AUPH
Aurinia Pharmaceuticals Inc. · Healthcare · Market cap $2.3B
Insiders sold $546K net in the last 90 days ·1 seller, 0 buyers· latest Form 4 filed Sep 11, 2026
Insider Buying
$25.1M
reported purchases (SEC code P)
Insider Selling
$546K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Sep 11, 2026
Robertson Stephen P.
Aurinia Pharmaceuticals Inc. (AUPH) has 24 SEC Form 4 filings (41 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Sep 11, 2026.
Inside the rolling window, 2 insiders at Aurinia Pharmaceuticals Inc. reported 6 open-market purchases totaling $25.1M and 2 open-market sales totaling $546K. The most active filer is Chief Executive Officer TANG KEVIN with 6 filings. Insiders have net bought $11.9M over the trailing 6 months. The largest single insider purchase in this window was $5.3M by Chief Executive Officer TANG KEVIN on Jun 1, 2026. The most recent open-market filing is a sale of 11,939 shares by Chief Legal Officer Robertson Stephen P., dated Sep 10, 2026, worth $190K.
- Industry:Biotechnology
- CEO:Kevin C. Tang
- Employees:128
- HQ:Edmonton, AB, CA
- IPO:2014-09-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Legal Officer | Sale | 11,939 | $190K | Sep 11 | +5.3% | SEC ↗ | |
Robertson Stephen P.First filing | Chief Legal Officer | Sale | 20,975 | $356K | Aug 26 | +2.5% | SEC ↗ |
TANG KEVINFirst in 3 months | Chief Executive Officer | Purchase | 264,981 | $4.1M | Jun 3 | +8.2% | SEC ↗ |
TANG KEVINFirst in 3 months | Chief Executive Officer | Purchase | 343,620 | $5.3M | Jun 3 | +8.2% | SEC ↗ |
TANG KEVINFirst in 3 months | Chief Executive Officer | Purchase | 206,005 | $3.1M | Jun 3 | +8.2% | SEC ↗ |
TANG KEVINFirst filing | Director | Purchase | 516,439 | $7.2M | Mar 3 | +19.9% | SEC ↗ |
TANG KEVINFirst filing | Director | Purchase | 199,353 | $2.8M | Mar 3 | — | SEC ↗ |
TANG KEVINFirst filing | Director | Purchase | 184,208 | $2.6M | Mar 3 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does AUPH have?
Aurinia Pharmaceuticals Inc. (AUPH) has 24 SEC Form 4 filings (41 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Sep 11, 2026.
When was the most recent SEC Form 4 filing for AUPH?
The most recent Form 4 filing for AUPH on Tracefour is dated Sep 11, 2026.
Who is the most active insider at AUPH?
The most active SEC Form 4 filer at AUPH in the rolling window is Chief Executive Officer TANG KEVIN, with 6 filings.
What is the net insider flow at AUPH over the last 6 months?
Over the trailing 180 days, insiders at AUPH have net bought $11.9M based on SEC Form 4 disclosures.
What was the largest insider purchase at AUPH?
The largest single insider open-market purchase at AUPH in the rolling window was $5.3M by Chief Executive Officer TANG KEVIN on 2026-06-01.
What is the total insider buy and sell value at AUPH in the current window?
Inside the rolling window, insiders at AUPH bought $25.1M and sold $546K based on SEC Form 4 filings.
Can I get alerts for AUPH insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Aurinia Pharmaceuticals Inc. (AUPH). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Aurinia Pharmaceuticals Inc. is in the Healthcare sector.